Lantheus Holdings, the parent company of Lantheus Medical Imaging, said that certain of its existing stockholders will sell 3 million shares of its common stock in a public secondary offering.
Credit Suisse will act as the underwriter for the offering. Lantheus said it will not receive any proceeds from the sale of the shares.
